as on October 23, 2025 at 1:29 am IST
Day's Low
Day's High
0.65%
Downside
2.29%
Upside
52 Week's Low
52 Week's High
32.11%
Downside
136.11%
Upside
Check Vir Biotechnology Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$850.2M
EPS (TTM)
-3.2635
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.58%
PE Ratio (TTM)
-2.35
Industry PE ratio
-0.8798722044728434
PEG Ratio
0EBITDA
-554.7M
Revenue (TTM)
19.0M
Profit Margin
0.00%
Return On Equity TTM
10867500.00%
Track how Vir Biotechnology Inc P/E has moved over time to understand its valuation trends.
Vir Biotechnology Inc in the last 5 years
Lowest (-49.76x)
September 30, 2021
Today (-2.35x)
October 23, 2025
Industry (-0.88x)
October 23, 2025
Highest (10.10x)
December 31, 2021
Today’s Price to Earnings Ratio: -2.35x
Compare market cap, revenue, PE, and other key metrics of Vir Biotechnology Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $850.2M | -82.37% | -2.35 | 0.00% | |
BUY | $63.1B | 252.62% | -505.15 | -12.96% | |
NA | $35.3B | NA | NA | -3.89% | |
BUY | $109.3B | 101.55% | 30.36 | 31.86% | |
BUY | $61.3B | 0.85% | 14.6 | 31.37% |
The Vir Biotechnology Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Vir Biotechnology Inc investment value today
Current value as on today
₹85,940
Returns
Returns from Vir Biotechnology Inc Stock
Dollar Returns*
₹4,557 (+4.56%)
Based on 13 analysts
69.23%
Buy
30.77%
Hold
0.00%
Sell
Based on 13 analysts, 69.23% of analysts recommend a 'BUY' rating for Vir Biotechnology Inc. Average target price of $17.22
Get share price movements and forecasts by analysts on Vir Biotechnology Inc.
What analysts predicted
64.46%UPSIDE
Target Price
$17.22
Current Price
$6.12
Analyzed by
13 Analysts
Target
$17.22
Vir Biotechnology Inc target price $17.22, a slight upside of 64.46% compared to current price of $6.12. According to 13 analysts rating.
Search interest for Vir Biotechnology Inc Stock has decreased by -4% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 7 days, VIR stock has moved up by 8.1%
Profit Spike
Netprofit is up for the last 2 quarters, -120.96M → -110.95M (in $), with an average increase of 9.0% per quarter
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 138.3% return, outperforming this stock by 208.8%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 60.7% return, outperforming this stock by 77.3%
Revenue Fall
Revenue is down for the last 3 quarters, 11.27M → 1.21M (in $), with an average decrease of 58.2% per quarter
Organisation | Vir Biotechnology Inc |
Headquarters | 1800 Owens Street, San Francisco, CA, United States, 94158 |
Industry | Commercial Services |
CEO | Dr. Marianne De Backer M.B.A., M.Sc., Ph.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Maninder Hora Ph.D. | Executive VP & Chief Technical Operations Officer |
Dr. Jennifer Eileen Towne Ph.D. | Executive VP & Chief Scientific Officer |
Mr. Jason O'Byrne M.B.A. | Executive VP & CFO |
Ms. Vanina de Verneuil J.D. | Executive VP, General Counsel & Corporate Secretary |
Mr. Brent Sabatini | Senior VP, Principal Accounting Officer & Chief Accounting Officer |
Dr. Louis J. Picker M.D. | Co-Founder & Scientific Advisor |
Mr. Toby Medaris M.Sc. | Senior Vice President of Human Resources |
Dr. Marianne De Backer M.B.A., M.Sc., Ph.D. | CEO & Director |
Dr. Mark D. Eisner M.D., M.P.H. | Executive VP & Chief Medical Officer |
Dr. Lawrence Corey M.D. | Co-Founder & Scientific Advisor |
Vir Biotechnology Inc share price today is $6.12 as on at the close of the market. Vir Biotechnology Inc share today touched a day high of $6.26 and a low of $6.08.
Vir Biotechnology Inc share touched a 52 week high of $14.45 on and a 52 week low of $4.16 on . Vir Biotechnology Inc stock price today i.e. is closed at $6.12,which is 57.65% down from its 52 week high and 47.29% up from its 52 week low.
Vir Biotechnology Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Vir Biotechnology Inc (VIR) shares with as little as ₹87.755 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹877.55 in Vir Biotechnology Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Vir Biotechnology Inc share’s latest price of $6.12 as on October 23, 2025 at 1:29 am IST, you will get 1.6340 shares of Vir Biotechnology Inc. Learn more about
fractional shares .
Vir Biotechnology Inc stock has given -82.37% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?